FRONTLINE CARE SOLUTIONS LTD Filleted Accounts Cover |
Company No. 13072372 | |||||||||
FRONTLINE CARE SOLUTIONS LTD Directors Report Registrar |
The Directors present their report and the accounts for the year ended 31 December 2025. | |||||||||
Principal activities | |||||||||
Directors | |||||||||
The Directors who served at any time during the year were as follows: | |||||||||
P. John | |||||||||
N. KAIPPILLIL CHACKOCHAN | |||||||||
Signed on behalf of the board | |||||||||
N. KAIPPILLIL CHACKOCHAN | |||||||||
Director | |||||||||
20 August 2026 | |||||||||
FRONTLINE CARE SOLUTIONS LTD Balance Sheet Registrar |
at | ||||||||||
Company No. | Notes | 2025 | 2024 | |||||||
£ | £ | |||||||||
Fixed assets | ||||||||||
Tangible assets | 5 | |||||||||
Current assets | ||||||||||
Debtors | 6 | |||||||||
Cash at bank and in hand | ||||||||||
Creditors: Amount falling due within one year | 7 | ( | ( | |||||||
Net current assets | ||||||||||
Total assets less current liabilities | ||||||||||
Net assets | ||||||||||
Capital and reserves | ||||||||||
Called up share capital | ||||||||||
Profit and loss account | 9 | |||||||||
Total equity | ||||||||||
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account. | ||||||||||
Approved by the board on 20 August 2026 and signed on its behalf by: | ||||||||||
N. KAIPPILLIL CHACKOCHAN | ||||||||||
Director | ||||||||||
20 August 2026 | ||||||||||
FRONTLINE CARE SOLUTIONS LTD Notes to the Accounts Registrar |
for the year ended 31 December 2025 | ||||||||||||||
1 | General information | |||||||||||||
FRONTLINE CARE SOLUTIONS LTD is a private company limited by shares and incorporated in England and Wales. | ||||||||||||||
Its registered number is: 13072372 | ||||||||||||||
Its registered office is: | ||||||||||||||
2 | Accounting policies | |||||||||||||
Revenue recognition | ||||||||||||||
for estimated customer returns, rebates and other similar allowances. Revenue from the sale of goods is recognised when all the following conditions are satisfied: • the Company has transferred to the buyer the significant risks and rewards of ownership of the goods; • the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold; • the amount of revenue can be measured reliably; • it is probable that the economic benefits associated with the transaction will flow to the Company; and • the costs incurred or to be incurred in respect of the transaction can be measured reliably. Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed. | ||||||||||||||
Tangible fixed assets and depreciation | ||||||||||||||
At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss. | ||||||||||||||
Furniture, fittings and equipment | ||||||||||||||
Research and development costs | ||||||||||||||
Expenditure on research and development is written off in the year it is incurred unless it meets the criteria to allow it to be capitalised. Costs of research are always written off in the year in which they are incurred. Where development costs are recognised as an asset, they are amortised over the period expected to benefit from them. Amortisation of the capitalised costs begins once the developed product comes into use, typically at rate of 33.33% straight line. | ||||||||||||||
Taxation | ||||||||||||||
Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period. | ||||||||||||||
Freehold investment property | ||||||||||||||
No depreciation is provided in respect of investment properties. | ||||||||||||||
Investments | ||||||||||||||
Stocks | ||||||||||||||
When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of inventories recognised as an expense in the period in which the reversal occurs. Work in progress is reflected in the accounts on a contract by contract basis by recording revenue and related costs as contract activity progresses. | ||||||||||||||
Trade and other debtors | ||||||||||||||
Trade and other creditors | ||||||||||||||
Foreign currencies | ||||||||||||||
Provisions | ||||||||||||||
Provisions are charged as an expense to the profit and loss account in the year that the Company becomes aware of the obligation, and are measured at the best estimate at balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties. When payments are eventually made, they are charged to the provision carried in the balance sheet. | ||||||||||||||
3 | Employees | |||||||||||||
2025 | 2024 | |||||||||||||
Number | Number | |||||||||||||
The average monthly number of employees (including directors) during the year was: | ||||||||||||||
4 | Taxation | |||||||||||||
(a) Tax on profit on ordinary activities | 2025 | 2024 | ||||||||||||
The tax charge is made up as follows: | £ | £ | ||||||||||||
UK corporation tax | ||||||||||||||
Charge for the period | ||||||||||||||
Total corporation tax | ||||||||||||||
Tax on profit on ordinary activities | ||||||||||||||
(b) Factors affecting the total tax charge for the period | ||||||||||||||
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The differences are reconciled below: | ||||||||||||||
Higher | 2025 | 2024 | ||||||||||||
2127 | £ | £ | ||||||||||||
Profit on ordinary activities before tax | ||||||||||||||
Standard rate of corporation tax in the United Kingdom | ||||||||||||||
Profit on ordinary activities multiplied by standard rate of corporation tax in the United Kingdom | ||||||||||||||
Expenses not deductible for tax purposes | ( | |||||||||||||
Tax on profit on ordinary activities | ||||||||||||||
5 | Tangible fixed assets | |||||||||||||
Fixtures, fittings and equipment | Total | |||||||||||||
£ | £ | |||||||||||||
Cost or revaluation | ||||||||||||||
At 1 January 2025 | ||||||||||||||
At 31 December 2025 | ||||||||||||||
Depreciation | ||||||||||||||
At 1 January 2025 | ||||||||||||||
Charge for the year | ||||||||||||||
At 31 December 2025 | ||||||||||||||
Net book values | ||||||||||||||
At 31 December 2025 | ||||||||||||||
At 31 December 2024 | 800 | 800 | ||||||||||||
6 | Debtors | |||||||||||||
2025 | 2024 | |||||||||||||
£ | £ | |||||||||||||
Corporation tax recoverable | ||||||||||||||
Loans to directors | ||||||||||||||
7 | Creditors: | |||||||||||||
amounts falling due within one year | ||||||||||||||
2025 | 2024 | |||||||||||||
£ | £ | |||||||||||||
Taxes and social security | ||||||||||||||
Accruals and deferred income | ||||||||||||||
8 | Share Capital | |||||||||||||
20 Ordinary shares of £1 each fully paid. | ||||||||||||||
9 | Reserves | |||||||||||||
10 | Dividends | |||||||||||||
2025 | 2024 | |||||||||||||
£ | £ | |||||||||||||
Dividends for the period: | ||||||||||||||
Dividends paid in the period | - | - | ||||||||||||
Dividends accrued at the period end | 80,000 | 80,000 | ||||||||||||
80,000 | ||||||||||||||
Dividends by type: | ||||||||||||||
Non-equity preference dividends | ||||||||||||||
Equity dividends | ||||||||||||||
80,000 | 80,000 | |||||||||||||
11 | Advances and credits to directors | |||||||||||||
2025 | ||||||||||||||
£ | ||||||||||||||
At 1 January 2025 | ||||||||||||||
Advanced in the period | ||||||||||||||
Amounts repaid in the period | ||||||||||||||
At 31 December 2025 | ||||||||||||||